ArticleNature communications2026
Hi-Compass: a depth-aware deep learning framework for predicting cell-type-specific 3D genome organization from single-cell to spatial resolution.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of deep learning in crop research: From genomics to phenomics.The plant genome · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Three-dimensional genome organization controls cell-type-specific gene expression through chromatin interactions, yet systematic analysis across diverse cellular contexts remains limited by experimental constraints. Here we present Hi-Compass, a depth-aware deep learning framework that predicts cell-type-specific chromatin organization using only chromatin accessibility data as cell-type-specific input. By dynamically accommodating variability in sequencing depth, Hi-Compass enables robust predictions across the full spectrum of data scales, from sparse single-cell to high-coverage bulk profiles. Benchmarking shows that Hi-Compass achieves superior concordance with experimental Hi-C data compared to existing methods, with particularly strong recovery of high-confidence chromatin loops. Applied to peripheral blood and embryonic heart datasets, Hi-Compass resolves cell-type-specific chromatin interactions and systematically links disease-associated variants to putative target genes. The framework further enables spatially resolved chromatin interaction prediction in hippocampal tissue and demonstrates cross-species applicability through fine-tuning to mouse systems. Hi-Compass expands the capacity to study three-dimensional genome regulation across biological scales and species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.